Early research (Phase 1)Study completedNCT04528719
What this trial is testing
A Dose Escalation Study to Evaluate Safety, Reactogenicity, and Immunogenicity of mRNA-1345 in Healthy Adults and in Children Who Are Respiratory Syncytial Virus (RSV)-Seropositive
Who this might be right for
Respiratory Syncytial Virus
ModernaTX, Inc. 651